BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots

PHASE3CompletedINTERVENTIONAL
Enrollment

2,175

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

September 20, 2021

Study Completion Date

September 20, 2021

Conditions
COVID
Interventions
BIOLOGICAL

BCG vaccine (Freeze-dried)

single dose of BCG vaccine (Freeze-dried) manufactured by Serum Institute of India, Pune. The composition of BCG vaccine is Live, attenuated BCG (Bacillus Calmette-Guerin Strain). (Each 1 ml contains between 2 x 106 and 8 x 106 Colony Forming Units (C.F.U.) with Diluent: Sodium Chloride Injection I.P.)

Trial Locations (1)

600031

Tuberculosis Research Centre, Chennai

All Listed Sponsors
collaborator

ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu

UNKNOWN

collaborator

All India Institute of Medical Sciences

OTHER

collaborator

National Institute for Research in Environmental Health, Bhopal, Madhya Pradesh

UNKNOWN

collaborator

National Institute of Occupational Health, Ahmedabad, Gujarat

UNKNOWN

collaborator

King Edward Memorial Hospital

OTHER

collaborator

National Institute for Implementation Research on Non-Communicable Disease

UNKNOWN

lead

Tuberculosis Research Centre, India

OTHER_GOV

NCT04475302 - BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots | Biotech Hunter | Biotech Hunter